Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sparano

Showing results (21-30 of 293) with videos related to

Pageof 30
Sort By:
BMC Medicine|August 18, 2015
Progress in adjuvant chemotherapy for breast cancer: an overviewJesus Anampa, Della Makower, Joseph A Sparano
Therapeutic Advances in Medical Oncology|August 19, 2021
The clinical utility of gene expression assays in breast cancer patients with 0-3 involved lymph nodesMali Barbi, Della Makower, Joseph A Sparano
Medical Oncology (Northwood, London, England)|December 1, 1995
Rhabdomyolysis: an unusual complication of cytotoxic chemotherapyR J Levy, J A Sparano, G Khan
Clinical Breast Cancer|March 20, 2002
Phase I/II trial of gemcitabine plus cyclophosphamide in patients with metastatic breast carcinoma previously treated with taxanesHuda S Salman, Katie Tanaka, Joseph A Sparano
Organic Letters|June 5, 2004
Effect of binding and conformation on fluorescence quenching in new 2',7'-dichlorofluorescein derivativesBrian A Sparano, Shatrughan P Shahi, Kazunori Koide
Surgical Oncology Clinics of North America|July 13, 2010
Clinical application of gene expression profiling in breast cancerJoseph A Sparano, Melissa Fazzari, Paraic A Kenny
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Translating genomic research into clinical practice: promise and pitfallsJoseph A Sparano, Harry Ostrer, Paraic A Kenny
Advances in Hematology|May 10, 2012
Paradigms and Controversies in the Treatment of HIV-Related Burkitt LymphomaAdam M Petrich, Joseph A Sparano, Samir Parekh
Future Oncology (London, England)|March 25, 2006
Clinical application of molecular profiling in breast cancerJoseph A Sparano, Melissa J Fazzari, Geoffrey Childs
Expert Opinion on Pharmacotherapy|March 1, 2021
Perspectives on PARP inhibitors as pharmacotherapeutic strategies for breast cancerSun Young Oh, Shafia Rahman, Joseph A Sparano
Pageof 30

Showing results (21-30 of 293) with videos related to

Sort By:
Pageof 30
BMC Medicine|August 18, 2015
Progress in adjuvant chemotherapy for breast cancer: an overviewJesus Anampa, Della Makower, Joseph A Sparano
Therapeutic Advances in Medical Oncology|August 19, 2021
The clinical utility of gene expression assays in breast cancer patients with 0-3 involved lymph nodesMali Barbi, Della Makower, Joseph A Sparano
Medical Oncology (Northwood, London, England)|December 1, 1995
Rhabdomyolysis: an unusual complication of cytotoxic chemotherapyR J Levy, J A Sparano, G Khan
Clinical Breast Cancer|March 20, 2002
Phase I/II trial of gemcitabine plus cyclophosphamide in patients with metastatic breast carcinoma previously treated with taxanesHuda S Salman, Katie Tanaka, Joseph A Sparano
Organic Letters|June 5, 2004
Effect of binding and conformation on fluorescence quenching in new 2',7'-dichlorofluorescein derivativesBrian A Sparano, Shatrughan P Shahi, Kazunori Koide
Surgical Oncology Clinics of North America|July 13, 2010
Clinical application of gene expression profiling in breast cancerJoseph A Sparano, Melissa Fazzari, Paraic A Kenny
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2013
Translating genomic research into clinical practice: promise and pitfallsJoseph A Sparano, Harry Ostrer, Paraic A Kenny
Advances in Hematology|May 10, 2012
Paradigms and Controversies in the Treatment of HIV-Related Burkitt LymphomaAdam M Petrich, Joseph A Sparano, Samir Parekh
Future Oncology (London, England)|March 25, 2006
Clinical application of molecular profiling in breast cancerJoseph A Sparano, Melissa J Fazzari, Geoffrey Childs
Expert Opinion on Pharmacotherapy|March 1, 2021
Perspectives on PARP inhibitors as pharmacotherapeutic strategies for breast cancerSun Young Oh, Shafia Rahman, Joseph A Sparano
Pageof 30